Coumarin‐modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells
Archiv der Pharmazie · 2024-09 · 357 (9)
DOI: 10.1002/ardp.202400271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 12.06.2024. Verfasst von Silvio Jakopec und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Zagreb, Croatia. Hauptthemen laut MEDLINE: Coumarins, Antineoplastic Agents, Cell Proliferation, Ruthenium. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: The European Fund for Regional Development, Croatian Science Foundation.
Abstract (Originalsprache)
Among ruthenium complexes studied as anticancer metallodrugs, NKP‐1339, NAMI‐A, RM175, and RAPTA‐C have already entered clinical trials due to their potent antitumor activity demonstrated in preclinical studies and reduced toxicity in comparison with platinum drugs. Considering the advantages of ruthenium‐based anticancer drugs and the cytostatic activity of organometallic complexes with triazole‐ and coumarin‐derived ligands, we set out to synthesize Ru(II) complexes of coumarin‐1,2,3,‐triazole hybrids ( L ) with the general formula [Ru( L )( p ‐cymene)(Cl)]ClO 4 . The molecular structure of the complex [Ru( 2a )( p ‐cymene)(Cl)]ClO 4 ( 2a Ru ) was determined by single‐crystal X‐ray diffraction, which confirmed the coordination of the ligand to the central ruthenium(II) cation by bidentate mode of coordination. Coordination with Ru(II) resulted in the enhancement of cytostatic activity in HepG2 hepatocellular carcinoma cells and PANC‐1 pancreatic cancer cells. Coumarin derivative 2a positively regulated the expression and activity of c‐Myc and NPM1 in RKO colon carcinoma cells, while the Ru(II) half‐sandwich complex 2c Ru induced downregulation of AKT and ERK signaling in PANC‐1 cells concomitant with reduced intracellular levels of reactive oxygen species. Altogether, our findings indicated that coumarin‐modified half‐sandwich Ru(II) complexes held potential as anticancer agents against gastrointestinal malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Zagreb, Croatia.
- Centre for Applied Bioanthropology, Institute for Anthropological Research, Zagreb, Croatia.
- Division of Materials Chemistry, Ruđer Bošković Institute, Zagreb, Croatia.
Förderung
- The European Fund for Regional Development
- Croatian Science Foundation
Zitieren
APA
Jakopec, S., Hamzic, L. F., Bočkor, L., Car, I., Perić, B., Kirin, S. I., Sedić, M., & Raić-Malić, S. (2024). Coumarin‐modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells. Archiv der Pharmazie, 357(9). https://doi.org/10.1002/ardp.202400271
Vancouver
Jakopec S, Hamzic LF, Bočkor L, Car I, Perić B, Kirin SI, et al. Coumarin‐modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells. Archiv der Pharmazie. 2024;357(9). doi:10.1002/ardp.202400271
BibTeX
@article{Jakopec2024,
author = {Jakopec, Silvio and Hamzic, Lejla F and Bočkor, Luka and Car, Iris and Perić, Berislav and Kirin, Srećko I and Sedić, Mirela and Raić-Malić, Silvana},
title = {Coumarin‐modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells},
journal = {Archiv der Pharmazie},
year = {2024},
volume = {357},
number = {9},
doi = {10.1002/ardp.202400271}
}
EUVIMED